IDEXX Laboratories, Inc. vs Lennar Corporation — how do they compare? IDEXX Laboratories, Inc. trades at $589.8 (market cap $46.22B), while Lennar Corporation trades at $87.36 (market cap $21.05B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.2× Lennar Corporation's market cap, and Lennar Corporation pays a 2.28% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | LEN | |
|---|---|---|
Market Cap | $46.22B | $21.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $142.40 |
52-Week Low | $526.44 | $81.84 |
Enterprise Value | $47.12B | $24.93B |
Dividend Yield | — | 2.28% |
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →